초록 ▼

A medical device is adapted for at least partial implantation into a body and includes first and second sections along the length of the device. A first therapeutic agent is associated with the first section and a second therapeutic agent is associated with the second section. The first therapeutic

A medical device is adapted for at least partial implantation into a body and includes first and second sections along the length of the device. A first therapeutic agent is associated with the first section and a second therapeutic agent is associated with the second section. The first therapeutic agent can be one or more antiproliferative, such as paclitaxel, a paclitaxel derivative, or a paclitaxel pro-drug, anti-coagulant, antithrombotic, thrombolytic, fibrinolytic, or combination thereof. The second therapeutic agent can be one or more antimicrobials, such as one or more antibiotics. Each of the first and second therapeutic agents can either be posited on one or more surfaces of the respective section, or impregnated within the section. The device can include a separator to space the first and second sections. A method of making a medical device and a method of establishing access to a vessel within a body are also provided.

대표청구항 ▼

We claim: 1. A medical device for at least partial implantation comprising: a main body having a length extending between a first end and a second end, the main body including a second tube at least partially positioned within a lumen of a first tube to form an annular space between an interior sur

We claim: 1. A medical device for at least partial implantation comprising: a main body having a length extending between a first end and a second end, the main body including a second tube at least partially positioned within a lumen of a first tube to form an annular space between an interior surface of the first tube and an exterior surface of the second tube, the second tube having a lumen extending from the first end to the second end; a first section along the length of the main body proximate the first end of said main body and having a first therapeutic agent, said first therapeutic agent comprising one or more members selected from the group consisting of antiproliferatives, anticoagulants, antithrombotics, thrombolytics, and fibrinolytics; and a second section along the length of the main body proximate the second end of said main body and having a second therapeutic agent, said second therapeutic agent comprising an antimicrobial, said first and second sections structured and aligned along said main body length such that said first therapeutic agent is at least substantially separated from said second therapeutic agent. 2. The medical device of claim 1, wherein the main body has a length such that when said device is at least partially implanted said first end accesses a body vessel and at least a portion of said second section is disposed within a subcutaneous space of a patient. 3. The medical device of claim 1, wherein the first therapeutic agent is positioned within the annular space between the first tube and the second tube. 4. The medical device of claim 3, wherein at least a portion of the first tube is formed of a porous material. 5. The medical device of claim 3, wherein the medical device further comprises a seal positioned between a first end of the first tube and a first end of the second tube to prevent escape of the first therapeutic agent directly from the annular space between the first tube and the second tube. 6. The medical device of claim 1, wherein the second therapeutic agent is positioned on or within the first tube. 7. The medical device of claim 1, wherein the medical device is characterized by the following: (a) the main body has a length such that when said device is at least partially implanted said first end accesses a body vessel and at least a portion of said second section is disposed within a subcutaneous space of a patient; (b) the first therapeutic agent is positioned within the annular space between the first tube and the second tube; (c) at least the portion of the first tube is formed of a porous material; (d) the medical device further comprises a seal positioned between a first end of the first tube and a first end of the second tube to prevent escape of the first therapeutic agent directly from the annular space between the first tube and the second tube; and (e) the second therapeutic agent is positioned on or within the first tube. 8. The medical device of claim 1, wherein the medical device further comprises an access line in communication with the annular space. 9. The medical device of claim 8, wherein the medical device further comprises a seal positioned proximal to the access line. 10. The medical device of claim 9, wherein at least a portion of the first tube is formed of a porous material. 11. The medical device of claim 10, wherein the first therapeutic agent is contained within the annular space distal to the seal. 12. The medical device of claim 11, wherein the second therapeutic agent is contained in one or more portions of the medical device selected from the group consisting of the annular space proximal to the seal, on a surface of the first tube, on a surface of the second tube, within the first tube and within the second tube. 13. The medical device of claim 1, wherein the medical device comprises a catheter forming the main body and having the first section and the second section positioned along the length of the second tube. 14. The medical device of claim 13, wherein the first section of the catheter comprises a coating of the first therapeutic agent on the exterior surface of the second tube. 15. The medical device of claim 14, wherein the second section of the catheter comprises the second therapeutic agent coated on the exterior surface of the second tube, proximal to the first section. 16. The medical device of claim 13, wherein at least the portion of the second tube is formed of a porous material forming a portion of the exterior surface of the catheter. 17. The medical device of claim 13, wherein the catheter has a length such that when said catheter is at least partially implanted said first end accesses a body vessel and at least a portion of said second section is disposed within a subcutaneous space of a patient. 18. The medical device of claim 1, wherein (a) the medical device further comprises an access line in communication with the annular space; (b) the medical device further comprises a seal positioned proximal to the access line; (c) at least a portion of the first tube is formed of a porous material; (d) the first therapeutic agent is contained within the annular space distal to the seal; and (e) the second therapeutic agent is contained in one or more portions of the medical device selected from the group consisting of: the annular space proximal to the seal, on a surface of the first tube, on a surface of the second tube, within the first tube and within the second tube. 19. The medical device of claim 11, wherein the second therapeutic agent is contained in one or more portions of the medical device selected from the group consisting of: the annular space proximal to the seal, on a surface of the first tube, and on a surface of the second tube. 20. A method of establishing access to a vessel of the body, the method comprising (a) implanting a distal portion of a medical device within a body vessel with a proximal portion of the medical device outside the body vessel, the medical device including: (i) a main body having a length extending between a first end and a second end, the main body including a second tube at least partially positioned within a lumen of a first tube to form an annular space between an interior surface of the first tube and an exterior surface of the second tube, the second tube having a lumen extending from the first end to the second end; (ii) a first section along the length of the main body proximate the first end of said main body and having a first therapeutic agent, said first therapeutic agent comprising one or more members selected from the group consisting of antiproliferatives, anticoagulants, antithrombotics, thrombolytics, and fibrinolytics; and (iii) a second section along the length of the main body proximate the second end of said main body and having a second therapeutic agent, said second therapeutic agent comprising an antimicrobial, said first and second sections structured and aligned along said main body length such that said first therapeutic agent is at least substantially separated from said second therapeutic agent; and (b) forming an interface between the distal portion and the vessel to provide access to the vessel through the lumen of the second tube.